About Allovir (ALVR)
AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more
- USD0.45
- USD0.45
- USD0.42
- USD1.05
- -11.10%
- --
- 213.87k
- 398.16k
- 51M
- 0.38
- -42.40%
Stock News
2 hours ago
Oil prices tick higher after snapping 3-day winning streak
MarketWatch
8 hours ago
Exxon Mobil Is Futureproofing Operations
SeekingAlpha
8 hours ago
Yen Jumps As Ueda Says Rate Hike Being Considered And Soft CPI Helps UK Gilts
SeekingAlpha
8 hours ago
ClearBridge Large Cap Growth Fund Q4 2024 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
